
Bayer Crop Science Advances Performance Turnaround Amid Litigation Progress and Portfolio Reshaping
Key Takeaways
- •Crop Science sales hit €21.6bn (~$23.5bn), +1.1% currency‑adjusted
- •Corn seed and traits revenue rose 13.2% year‑over‑year
- •Monsanto Roundup settlement proposal totals $7.25bn, preliminarily approved
- •Bayer invests C$45m ($33m) in Canadian Canola Innovation Centre
- •New wireless FieldView‑John Deere integration streamlines farm data sharing
Pulse Analysis
Bayer Crop Science is in the second year of a two‑year turnaround that began after the 2018 Monsanto acquisition. The division posted full‑year 2025 sales of €21.6 billion, roughly $23.5 billion, a modest 1.1 % rise on a currency‑adjusted basis, and highlighted a 13.2 % jump in corn seed and traits revenue. Management emphasized a €2 billion cost‑saving target through its Dynamic Shared Ownership model, aiming to lift cash generation ahead of the 2027 product pipeline. The plan also includes divesting low‑performing assets to sharpen focus.
At the same time, Bayer is reshaping its crop‑protection portfolio toward higher‑margin, science‑driven solutions. The Colombian launch of Plenexos, a low‑dose insecticide, is slated for Brazilian registration, while the EPA cleared a low‑volatility dicamba under the Stryax brand for 34 states. New seed and treatment products such as Sivanto Energy, EverGol Rise, and the camelina‑focused newgold line expand the company’s reach into canola and renewable‑fuel markets. A C$45 million ($33 million) commitment to a Canola Innovation Centre in Winnipeg underscores Bayer’s long‑term bet on Canadian agronomy research. The centre will collaborate with local universities to accelerate breeding cycles.
Digital integration also features prominently in Bayer’s strategy. A partnership with John Deere now lets farmers push FieldView prescriptions directly into the Operations Center, eliminating manual file transfers and accelerating decision‑making on the ground. This wireless workflow, initially rolled out to Preceon Ground Breakers participants, is expected to reach a broader U.S. audience later in 2026, reinforcing Bayer’s position in the emerging ag‑tech ecosystem. Farmers adopting the workflow report faster pest‑management decisions and lower input costs. Combined with the pending $7.25 billion Roundup settlement, these moves aim to reduce litigation exposure while unlocking new revenue streams from precision agriculture.
Bayer Crop Science Advances Performance Turnaround Amid Litigation Progress and Portfolio Reshaping
Comments
Want to join the conversation?